In November 2023, the Food and Drug Administration (FDA) approved Zepbound (tirzepatide) for long-term weight management ... They can also work with you to create a custom weight loss plan ...

The biotech has named Jamie Coleman its chief commercial officer, per a Monday announcement, putting her in charge of the ...

Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

Zepbound is a medicine you can obtain only by prescription, and it's typically used to address obesity and other ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could ... without coverage depending on their dosage, some point to the long-term cost savings if obese Americans lose weight and avoid ...

Lilly is considering expanding the availability of lower-priced vials of its blockbuster obesity drug Zepbound ...

This helps Zepbound work effectively. Zepbound is used in combination with exercise and a low calorie diet. For full details about dosing, see this Zepbound dosage article. Zepbound is a ...

On Dec. 26, the FDA officially declared the shortage over, a long-sought victory for Lilly. Lilly recorded $3 billion in sales from Zepbound in the first nine months of the year, according to a ...

Why it matters: Lilly's growth prospects are driven by Mounjaro and Zepbound, and shortfalls in sales could portend weaker long-term potential ... but they show their work, distinguish facts ...

Sales of Eli Lilly's (LLY) blockbuster diabetes and weight loss drugs, Mounjaro and Zepbound, are very strong ... Cookies are essential for making our site work. By using our site, you consent to the ...